Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation. [electronic resource]
Producer: 20100224Description: 35-46 p. digitalISSN:- 1179-2027
- Antibodies, Monoclonal -- economics
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- economics
- Cost-Benefit Analysis
- Drug Resistance, Neoplasm
- France
- Humans
- Long-Term Care
- Lymphoma, Follicular -- drug therapy
- Markov Chains
- National Health Programs
- Quality-Adjusted Life Years
- Recurrence
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.